Key facts
- This page summarizes Claude Nicaise's Form 4 filing for Chemomab Therapeutics Ltd. (CMMB).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 23 Mar 2023, 07:36.
Claude Nicaise - 16 Mar 2023 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)
- Reporting relationship
- Director
- Issuer ticker
- CMMB
- Reported as of
- 16 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Mar 2023, 07:36:58 UTC
- Prior SEC filing
- 08 Mar 2023
- Next SEC filing
- 26 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Rudolph, Esq., Attorney-in-Fact for Claude Nicaise
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Claude Nicaise filed Form 4 for Chemomab Therapeutics Ltd. (CMMB) on 23 Mar 2023.
Change
- Previous filing in this sequence was filed on 08 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMMB
transaction
Derivative
Option to Purchase American Depositary Shares
Award
- Transaction value
- $0
- Shares
- +6,857
- Change %
- Price
- $0.000000
- Shares after
- 6,857
- Date
- 16 Mar 2023
- Ownership
- Direct
- Underlying class
- American Depositary Shares
- Underlying amount
- 6,857
- Exercise price
- $1.62
- Footnotes
- F1, F2
CMMB
transaction
Derivative
Option to Purchase American Depositary Shares
Award
- Transaction value
- $0
- Shares
- +6,820
- Change %
- Price
- $0.000000
- Shares after
- 6,820
- Date
- 16 Mar 2023
- Ownership
- Direct
- Underlying class
- American Depositary Shares
- Underlying amount
- 6,820
- Exercise price
- $3.53
- Footnotes
- F2, F3, F4
CMMB
transaction
Derivative
Option to Purchase American Depositary Shares
Award
- Transaction value
- $0
- Shares
- +11,884
- Change %
- Price
- $0.000000
- Shares after
- 11,884
- Date
- 16 Mar 2023
- Ownership
- Direct
- Underlying class
- American Depositary Shares
- Underlying amount
- 11,884
- Exercise price
- $27.26
- Footnotes
- F2, F3, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
These options were granted as per the annual grant of options to directors. These options vest and become exercisable in their entirety on March 16, 2024, subject to the Reporting Person's continued service.
Footnote F2
Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
Footnote F3
No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Footnote F4
These options vested and became exercisable in their entirety on March 16, 2023. These options were granted as per the annual grant of options to directors.
Footnote F5
These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.